Choi K - Search Results

1

Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.

Shin JH, Park HB, Oh YM, Lim DP, Lee JE, Seo HH, Lee SJ, Eom HS, Kim IH, Lee SH, Choi K. Shin JH, et al. Among authors: choi k. Blood. 2012 Jun 14;119(24):5678-87. doi: 10.1182/blood-2011-09-380519. Epub 2012 Apr 26. Blood. 2012. PMID: 22538857 Free article.

2

Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling.

Lee JS, Lee JE, Oh YM, Park JB, Choi H, Choi CY, Kim IH, Lee SH, Choi K. Lee JS, et al. Among authors: choi k, choi h, choi cy. J Immunol. 2009 Dec 1;183(11):7178-86. doi: 10.4049/jimmunol.0803799. Epub 2009 Nov 13. J Immunol. 2009. PMID: 19915061

3

An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells.

Kim YH, Sung HJ, Kim S, Kim EO, Lee JW, Moon JY, Choi K, Jung JE, Lee Y, Koh SS, Rhee SG, Heo K, Kim IH. Kim YH, et al. Among authors: choi k. Cancer Lett. 2011 Dec 26;313(1):76-83. doi: 10.1016/j.canlet.2011.08.027. Epub 2011 Sep 3. Cancer Lett. 2011. PMID: 21963224

4

p53 acetylation enhances Taxol-induced apoptosis in human cancer cells.

Kim JH, Yoon EK, Chung HJ, Park SY, Hong KM, Lee CH, Lee YS, Choi K, Yang Y, Kim K, Kim IH. Kim JH, et al. Among authors: choi k. Apoptosis. 2013 Jan;18(1):110-20. doi: 10.1007/s10495-012-0772-8. Apoptosis. 2013. PMID: 23161364

5

Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.

Shin SP, Seo HH, Shin JH, Park HB, Lim DP, Eom HS, Bae YS, Kim IH, Choi K, Lee SJ. Shin SP, et al. Among authors: choi k. Mol Ther. 2013 Mar;21(3):688-95. doi: 10.1038/mt.2012.252. Epub 2013 Jan 22. Mol Ther. 2013. PMID: 23337984 Free PMC article.

6

Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.

Goh AR, Shin SP, Jung NR, Ryu CH, Eom HS, Lee JH, Choi K, Lee SJ, Jung YS. Goh AR, et al. Among authors: choi k. Cancer Lett. 2015 Jan 28;356(2 Pt B):743-50. doi: 10.1016/j.canlet.2014.10.022. Epub 2014 Oct 24. Cancer Lett. 2015. PMID: 25449436

7

Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2.

Oh YM, Park HB, Shin JH, Lee JE, Park HY, Kho DH, Lee JS, Choi H, Okuda T, Kokame K, Miyata T, Kim IH, Lee SH, Schwartz RH, Choi K. Oh YM, et al. Among authors: choi k, choi h. Nat Commun. 2015 Oct 28;6:8698. doi: 10.1038/ncomms9698. Nat Commun. 2015. PMID: 26507712 Free PMC article.

8

Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy.

Shin JH, Park HB, Choi K. Shin JH, et al. Among authors: choi k. Immune Netw. 2016 Apr;16(2):134-9. doi: 10.4110/in.2016.16.2.134. Epub 2016 Apr 28. Immune Netw. 2016. PMID: 27162530 Free PMC article.

9

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.

Kim Y, Kim G, Kong BS, Lee JE, Oh YM, Hyun JW, Kim SH, Joung A, Kim BJ, Choi K, Kim HJ. Kim Y, et al. Among authors: choi k. J Clin Neurol. 2017 Apr;13(2):175-180. doi: 10.3988/jcn.2017.13.2.175. Epub 2017 Mar 6. J Clin Neurol. 2017. PMID: 28271642 Free PMC article.

10

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.

Park HB, Lee JE, Oh YM, Lee SJ, Eom HS, Choi K. Park HB, et al. Among authors: choi k. Exp Mol Med. 2017 Jul 28;49(7):e360. doi: 10.1038/emm.2017.104. Exp Mol Med. 2017. PMID: 28751785 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,140 results

Search Page

Filters